AAAAAA
Results: 26-30/30
Authors:
Gwathmey, JK
Kim, CS
Hajjar, RJ
Khan, F
DiSalvo, TG
Matsumori, A
Bristow, MR
Citation: Jk. Gwathmey et al., Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol, AM J P-HEAR, 45(5), 1999, pp. H1678-H1690
Authors:
Bowling, N
Walsh, RA
Song, GJ
Estridge, T
Sandusky, GE
Fouts, RL
Mintze, K
Pickard, T
Roden, R
Bristow, MR
Sabbah, HN
Mizrahi, JL
Gromo, G
King, GL
Vlahos, CJ
Citation: N. Bowling et al., Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart, CIRCULATION, 99(3), 1999, pp. 384-391
Authors:
Bristow, MR
Citation: Mr. Bristow, Mechanisms of development of heart failure in the hypertensive patient, CARDIOLOGY, 92, 1999, pp. 3-6
Authors:
Lowes, BD
Gill, EA
Abraham, WT
Larrain, JR
Robertson, AD
Bristow, MR
Gilbert, EM
Citation: Bd. Lowes et al., Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure, AM J CARD, 83(8), 1999, pp. 1201-1205
Authors:
Bristow, MR
Roden, RL
Lowes, BD
Gilbert, EM
Eichhorn, EJ
Citation: Mr. Bristow et al., The role of third-generation beta-blocking agents in chronic heart failure, CLIN CARD, 21(12), 1998, pp. 3-13